Update on systemic therapy for colorectal cancer: biologics take sides

DOI: 10.21037/tgh.2019.01.12

Keywords: Biologics, colorectal cancer (CRC), epidermal growth factor receptor (EGFR), immunotherapy, mismatch repair deficiency (MMR deficiency), sidedness

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text